0001140361-17-037017.txt : 20170929
0001140361-17-037017.hdr.sgml : 20170929
20170929191924
ACCESSION NUMBER: 0001140361-17-037017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170927
FILED AS OF DATE: 20170929
DATE AS OF CHANGE: 20170929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Unkart Edward W
CENTRAL INDEX KEY: 0001306267
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36830
FILM NUMBER: 171112857
MAIL ADDRESS:
STREET 1: 6 VALLEY OAK
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348911
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200915291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (857) 999-0075
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Therapeutics, Inc.
DATE OF NAME CHANGE: 20140916
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery, Inc
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery Inc
DATE OF NAME CHANGE: 20060105
4
1
doc1.xml
FORM 4
X0306
4
2017-09-27
0
0001348911
KalVista Pharmaceuticals, Inc.
KALV
0001306267
Unkart Edward W
C/O KALVISTA PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, BLDG 200, STE 2203
CAMBRIDGE
MA
02139
1
0
0
0
Director Stock Option (Right to Buy)
6.71
2017-09-27
4
A
0
6000
0
A
2027-09-26
Common Stock
6000
6000
D
The option vests over a 12 month period: 1/12th on October 27, 2017, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.
/s/Benjamin Palleiko, Attorney-in-Fact
2017-09-29